Cargando…
TrkB-Targeted Therapy for Mucoepidermoid Carcinoma
The brain-derived neurotrophic factor (BDNF)/tyrosine receptor kinase B (TrkB) pathway was previously associated with key oncogenic outcomes in a number of adenocarcinomas. The aim of our study was to determine the role of this pathway in mucoepidermoid carcinoma (MEC). Three MEC cell lines (UM-HMC-...
Autores principales: | Wagner, Vivian P., Martins, Manoela D., Amoura, Esra, Zanella, Virgilio G., Roesler, Rafael, de Farias, Caroline B., Bingle, Colin D., Vargas, Pablo A., Bingle, Lynne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759804/ https://www.ncbi.nlm.nih.gov/pubmed/33255325 http://dx.doi.org/10.3390/biomedicines8120531 |
Ejemplares similares
-
Antitumor Activities and Cellular Changes Induced by TrkB Inhibition in Medulloblastoma
por: Thomaz, Amanda, et al.
Publicado: (2019) -
The transcriptional landscape of the cultured murine middle ear epithelium in vitro
por: Mulay, Apoorva, et al.
Publicado: (2021) -
Imbalance of neurotrophin receptor isoforms TrkB-FL/TrkB-T1 induces neuronal death in excitotoxicity
por: Vidaurre, Ó G, et al.
Publicado: (2012) -
Do Small Molecules Activate the TrkB Receptor in the Same Manner as BDNF? Limitations of Published TrkB Low Molecular Agonists and Screening for Novel TrkB Orthosteric Agonists
por: Pankiewicz, Piotr, et al.
Publicado: (2021) -
Differential epithelial expression of the putative innate immune molecule SPLUNC1 in Cystic Fibrosis
por: Bingle, Lynne, et al.
Publicado: (2007)